Christine Rückert, PhDSenior Scientist at CureVac AG
Christine Rueckert has joined the Research and Development team of CureVac as a scientist in 2016. She develops mRNA delivery technology for prophylactic and therapeutic vaccine applications in the department Product Design and Formulation.
Previously, she had postdoctoral and Research Associate positions at the University of Virgina (USA), Charité Berlin, Freie Universitaet Berlin, Helmholtz Centre for Infection Research Braunschweig (Germany) where she conducted research in biophysics, cell biology and immunology. She is an author of 23 research publications.
She studied biophysics at the Humboldt-Universitaet zu Berlin and molecular biology/immunology at Imperial College, London, and received her doctoral degree in Experimental Biophysics from the Humboldt-Universitaet zu Berlin.